Tuberous sclerosis: Epidemiology, genetics and progress towards treatment

Neuroepidemiology

Volumn 33, Issue 4, 2009, Pages 342-343

  Morrison, Patrick J ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HAMARTIN; TUBERIN;

ANGIOMYOLIPOMA; BRAIN CALCIFICATION; BRAIN CORTEX; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DISEASE COURSE; DNA DETERMINATION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; KIDNEY CARCINOMA; LEARNING DISORDER; MOLECULAR GENETICS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; SCREENING TEST; TUBEROUS SCLEROSIS;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; POPULATION DENSITY; POPULATION SURVEILLANCE; PREVALENCE; TAIWAN; TUBEROUS SCLEROSIS;

EID: 70350560457     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000254570     Document Type: Conference Paper

References (8)

1. Bourneville D: Sclérose tubéreuse des circonvolution cérébrales: Idiotie et épilepsie hemiplégique. Arch Neurol 1880; 1: 81-91.
2. Roach ES, Gomez MR, Northrup H: Tuberous sclerosis complex consensus conference: Revised clinical diagnostic criteria. J Child Neurol 1998;13:624-628.
3. Sampson JR, Scahill SJ, Stephenson JB, Mann L, Connor JM: Genetic aspects of tuberous sclerosis in the west of Scotland. J Med Genet 1989; 26: 28-31.
4. Webb DW, Fryer AE, Osborne JP: Morbidity associated with tuberous sclerosis: A population study. Dev Med Child Neurol 1996; 38: 146-155.
5. Fisher OD, Stevenson AC: Frequency of epiloia in Northern Ireland. Br J Prev Soc Med 1956; 10: 134-135.
6. Devlin LA, Shepherd CH, Crawford H, Morrison PJ: Tuberous sclerosis complex: Clinical features, diagnosis, and prevalence within Northern Ireland. Dev Med Child Neurol 2006; 48: 495-499.
7. Hong CH, Darling TN, Lee CH: Prevalence of tuberous sclerosis complex in Taiwan: A national population-based study. Neuroepidemiology 2009;33:335-341.
8. Lee N, Woodrum CL, Nobil AM, Rauktys AE, Messina MP, Dabora SL: Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models. BMC Pharmacol 2009; 9: 8.